Pacira BioSciences Q4 Adj. EPS $0.57 Misses $0.90 Estimate, Sales $196.873M Miss $200.424M Estimate.
Benzinga Newsdesk 8 months ago
EarningsEarnings MissesNews
Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.90 by 36.95 percent. This is a 37.36 percent decrease over earnings of $0.91 per share
Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.90 by 36.95 percent. This is a 37.36 percent decrease over earnings of $0.91 per share from the same period last year. The company reported quarterly sales of $196.873 million which missed the analyst consensus estimate of $200.424 million by 1.77 percent. This is a 5.14 percent increase over sales of $187.253 million the same period last year.